Pardee, T. S., Lee, K., Luddy, J., Maturo, C., Rodriguez, R., Isom, S., . . . Powell, B. L. (2014). A Phase I Study of the First-in-Class Anti-Mitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies.
Chicago ZitierstilPardee, Timothy S., et al. A Phase I Study of the First-in-Class Anti-Mitochondrial Metabolism Agent, CPI-613, in Patients With Advanced Hematologic Malignancies. 2014.
MLA ZitierstilPardee, Timothy S., et al. A Phase I Study of the First-in-Class Anti-Mitochondrial Metabolism Agent, CPI-613, in Patients With Advanced Hematologic Malignancies. 2014.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.